Kepley BioSystems News

Appeared in MD+DI on August 19, 2020. Antimicrobial fullerenes developed to attract pathogens could be used to infuse personal protective equipment (PPE) and medical garments.

Read More

Kepley BioSystems filed the second of two recent patents describing novel approaches to protective applications addressing the Coronavirus pandemic, as well as increasing antimicrobial resistance threats. Kepley researchers have invented a method to permanently infuse a substrate with antimicrobial functional fullerenes (modified buckyballs). Applications include synthetic or natural Personal Equipment (PPE), non-disposable medical garments and […]

Read More

Kepley BioSystems has completed patent work surrounding the technology for a novel air sterilization mask, as well as for controlled spaces to directly eliminate airborne viral, bacterial and fungal pathogens. The pro se patent has been submitted with the United States Patent and Trademark Office (USPTO) under a COVID-19 Prioritized Examination Pilot Program established to […]

Read More

The US Pharmacopoeia has cited the use of horseshoe crab-derived test reagents for ensuring the sterility of injectable drugs and implanted medical devices as the standard in lieu of more recently developed recombinant alternatives. This was first reported in Reuters by John Miller in Zurich and then in The New York Times on May 30, […]

Read More

While many aspects remain unknown, scientists are discovering more about the novel coronavirus SARS-CoV-2 that causes COVID-19 every day. Although still considered rare, they are learning it can be transmitted from humans to their pets. Recently, Duke University verified such a case with an infected pug in North Carolina (WRAL, 2020). In turn, the Centers […]

Read More

Kepley BioSystems Inc, a North Carolina biotech has just published the results of their endotoxin testing research in the Marine Conservation and Sustainability section of Frontiers in Marine Science. With grant funding from the National Science Foundation, the team validated novel methods of Atlantic horseshoe crab aquaculture for sustainable production of a resource used to […]

Read More

Greensboro, NC and Meteghan, NS – On March 3, 2020, Kepley BioSystems shipped several hundred synthetic crustacean baits for evaluation by a major lobster fishery in Canada under the leadership of industry experts, Clare Machine Works and Synergy Seafoods Limited. The effectiveness and palatability of the bait will also be studied in collaboration with the […]

Read More

The TEDx GREENSBORO event has been postponed due to the global pandemic. New dates to be determined. Kepley BioSystems president, Anthony Dellinger, has been invited to participate in a regional TEDx event on March 26, 2020, at the Greensboro Cultural Center. Following this year’s theme of “Risk,” Dellinger will join Greensboro’s most curious and innovative minds, […]

Read More

Last summer, the NC biotech team at Kepley BioSystems launched Kepley K9® Strategic Scent Stimulant for busy pet owners wanting more quality time with their “dawdling dogs” (and less time wasted while “sniffing” on walks). Soon thereafter, the team embarked on a study to see if the product could benefit shelter dogs (and the staff) […]

Read More